Soluble VEGFR‐1: A new biomarker of sorafenib‐related hypertension (i.e., sorafenib‐related is the compound adjective?)

E-ISSN： 1552-4604|55|4|478-479

ISSN： 0091-2700

Source： JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.55, Iss.4, 2015-04, pp. : 478-479

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A high baseline HBV load and antiviral therapy affect the survival of patients with advanced HBV‐related HCC treated with sorafenib

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 9, 2015-09 ,pp. : 2147-2154

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antiviral therapy in the improvement of survival of patients with hepatitis B virus‐related hepatocellular carcinoma treated with sorafenib

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 6, 2015-06 ,pp. : 1032-1039

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of Hepatitis C Virus Eradication on the Clinical Outcome of Patients with Hepatitis C Virus-Related Advanced Hepatocellular Carcinoma Treated with Sorafenib

Oncology, Vol. 92, Iss. 6, 2017-03 ,pp. : 335-346

Karger

Access to resources Recommend Favorite

Expression of pERK and VEGFR‐2 in advanced hepatocellular carcinoma and resistance to sorafenib treatment

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 8, 2015-08 ,pp. : 2001-2008

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sorafenib-Induced Tuberculosis Reactivation

Oncology Research and Treatment, Vol. 35, Iss. 9, 2012-08 ,pp. : 514-516

Karger

Access to resources Recommend Favorite